20.37

0.34% 0.07

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $20.37, with a volume of 178.29K. It is up +0.34% in the last 24 hours and up +15.61% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Previous Close:

$20.30

Open:

$20.38

24h Volume:

178.29K

Relative Volume:

1.07

Market Cap:

$1.23B

Revenue:

Net Income/Loss:

$-42.21M

P/E Ratio:

-16.70

EPS:

-1.22

Net Cash Flow:

$-33.16M

1W Performance:

+26.21%

1M Performance:

+15.61%

6M Performance:

+79.16%

1Y Performance:

+130.43%

1-Day Range:

$19.84

$21.47

1-Week Range:

$15.62

$21.47

52-Week Range:

$6.595

$22.69

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

Twitter

@PulseBioNPS

Next Earnings Date

2024-10-30

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	20.37	1.23B	0	-42.21M	-33.16M	-1.22
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Nov 26, 2024

Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 15, 2024

Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder, Top Key Executive Robert Duggan sees holdings value fall by 4.8% following recent drop - Simply Wall St

Nov 15, 2024

Nov 08, 2024

When the Price of (PLSE) Talks, People Listen - Stock Traders Daily

Nov 08, 2024

Creative Planning Purchases 11,667 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World

Nov 08, 2024

Nov 05, 2024

Pulse Biosciences (NASDAQ:PLSE) Trading 7.6% HigherStill a Buy? - MarketBeat

Nov 05, 2024

Nov 04, 2024

Critical Analysis: Pulse Biosciences (NASDAQ:PLSE) and Spectral AI (NASDAQ:MDAI) - Defense World

Nov 04, 2024

Nov 01, 2024

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024

Oct 31, 2024

Pulse Biosciences Reports Positive Data From Benign Thyroid Study - MarketWatch

Oct 31, 2024

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association - Business Wire

Oct 31, 2024

Pulse Biosciences Appoints David Kenigsberg, M.D. As Chief Medical Officer Of Electrophysiology - citybiz

Oct 31, 2024

Pulse Biosciences (NASDAQ:PLSE) Announces Earnings Results - MarketBeat

Oct 31, 2024

Pulse Biosciences Inc Reports Q3 2024 GAAP Net Loss of $12.7 Mil - GuruFocus.com

Oct 31, 2024

Pulse Biosciences (NASDAQ:PLSE) Shares Pass Below 50-Day Moving AverageWhat's Next? - MarketBeat

Oct 31, 2024